tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Vikram Purohit, 56 are a BUY (42.11%), 74 are a HOLD (55.64%), 3 are a SELL (2.26%).
Analyst Vikram Purohit, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 48.63% that have a potential upside of 45.78% achieved within 133 days.
Vikram Purohit’s has documented 306 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INCY, yte at 30-Oct-2024.
Analyst best performing recommendations are on ARQT (ARCUTIS BIOTHERAPEUTICS ).
The best stock recommendation documented was for ARQT (ARCUTIS BIOTHERAPEUTICS ) at 12/21/2023. The price target of $11 was fulfilled within 71 days with a profit of $8.4 (323.08%) receiving and performance score of 45.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$190
$83.54 (78.47%)
$180
1 days ago
(31-Jan-2025)
6/33 (18.18%)
$83.54 (78.47%)
108
Buy
$122
$15.54 (14.60%)
$106
1 months 1 days ago
(31-Dec-2024)
14/17 (82.35%)
$38.59 (46.27%)
243
Buy
$121
$14.54 (13.66%)
$107
1 months 20 days ago
(12-Dec-2024)
18/21 (85.71%)
$26.34 (27.83%)
223
Hold
$106
$-0.46 (-0.43%)
$95
5 months 26 days ago
(06-Aug-2024)
6/7 (85.71%)
$20.48 (23.95%)
71
Buy
$105
$-1.46 (-1.37%)
$111
5 months 26 days ago
(06-Aug-2024)
2/3 (66.67%)
$19.48 (22.78%)
167
Which stock is Vikram Purohit is most bullish on?
Which stock is Vikram Purohit is most reserved on?
What Year was the first public recommendation made by Vikram Purohit?
